Published in J Gynecol Oncol on March 15, 2017
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med (1999) 7.56
Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet (1997) 6.53
Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012. Cancer Res Treat (2015) 6.31
Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol (2000) 6.06
Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med (1999) 5.89
Global burden of human papillomavirus and related diseases. Vaccine (2012) 5.48
Improved survival with bevacizumab in advanced cervical cancer. N Engl J Med (2014) 4.01
Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol (2004) 3.85
Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group Study. J Clin Oncol (2005) 2.94
Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin (2016) 2.93
National cancer incidence for the year 2002 in Korea. Cancer Res Treat (2007) 1.88
Identification of a low-risk subset of patients with stage IB invasive squamous cancer of the cervix possibly suited to less radical surgical treatment. Gynecol Oncol (1995) 1.75
Prevalence of human papillomavirus infection in women in Busan, South Korea. Int J Cancer (2003) 1.71
Defining the priority of using 18F-FDG PET for recurrent cervical cancer. J Nucl Med (2004) 1.58
Incidence of cervical, endometrial, and ovarian cancer in Korea, 1999-2010. J Gynecol Oncol (2013) 1.56
Paclitaxel and cisplatin as first-line therapy in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol (1999) 1.53
Improved treatment for cervical cancer--concurrent chemotherapy and radiotherapy. N Engl J Med (1999) 1.45
Guidelines for the treatment of recurrent and metastatic cervical cancer. Oncologist (2002) 1.41
Current status of cervical cancer and HPV infection in Korea. J Gynecol Oncol (2009) 1.40
Follow-up for women after treatment for cervical cancer: a systematic review. Gynecol Oncol (2009) 1.27
Recent achievements and future developments in advanced and recurrent cervical cancer: trials of the Gynecologic Oncology Group. Semin Oncol (2009) 1.19
Pretreatment serum squamous cell carcinoma antigen: a newly identified prognostic factor in early-stage cervical carcinoma. J Clin Oncol (1996) 1.10
Pregnancy after radical trachelectomy: a real option? Gynecol Oncol (2005) 1.10
Laparoscopic versus open radical hysterectomy in early-stage cervical cancer: long-term survival outcomes in a matched cohort study. Ann Oncol (2011) 1.09
Early clinical outcomes and toxicity of intensity modulated versus conventional pelvic radiation therapy for locally advanced cervix carcinoma: a prospective randomized study. Int J Radiat Oncol Biol Phys (2013) 1.02
Efficacy of different types of treatment in FIGO stage IB2 cervical cancer in Korea: results of a multicenter retrospective Korean study (KGOG-1005). Int J Gynecol Cancer (2007) 1.01
Pregnancy outcomes in patients after radical trachelectomy. Am J Obstet Gynecol (2003) 0.98
Surgical treatment of recurrent cervical cancer: state of the art and new achievements. Gynecol Oncol (2008) 0.96
Conservative surgical methods for FIGO stage IA2 squamous cervical carcinoma and their role in preserving women's fertility. Gynecol Oncol (2004) 0.95
ACOG practice bulletin. Diagnosis and treatment of cervical carcinomas. Number 35, May 2002. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet (2002) 0.94
Prevalence of human papillomavirus and Chlamydia trachomatis infection among women attending cervical cancer screening in the Republic of Korea. Eur J Cancer Prev (2009) 0.93
Comparison of outcomes between radical hysterectomy followed by tailored adjuvant therapy versus primary chemoradiation therapy in IB2 and IIA2 cervical cancer. J Gynecol Oncol (2012) 0.93
Performance of FDG-PET/CT for diagnosis of recurrent uterine cervical cancer. Eur Radiol (2008) 0.90
The efficacy of conservative management after conization in patients with stage IA1 microinvasive cervical carcinoma. Acta Obstet Gynecol Scand (2009) 0.89
Interstitial reirradiation for recurrent gynecologic malignancies: results and analysis of prognostic factors. Gynecol Oncol (1993) 0.89
(18)F-FDG PET/CT is Useful for Pretreatment Assessment of the Histopathologic Type of Thymic Epithelial Tumors. Nucl Med Mol Imaging (2010) 0.87
Treatment patterns of FIGO Stage IB2 cervical cancer: a single-institution experience of radical hysterectomy with individualized postoperative therapy and definitive radiation therapy. Gynecol Oncol (2008) 0.86
Efficacy and oncologic safety of nerve-sparing radical hysterectomy for cervical cancer: a randomized controlled trial. J Gynecol Oncol (2015) 0.86
Recurrent cervical carcinoma after primary radical surgery. Am J Obstet Gynecol (1999) 0.86
Phase II trial of topotecan and cisplatin in persistent or recurrent squamous and nonsquamous carcinomas of the cervix. Gynecol Oncol (2002) 0.85
Class I versus class III radical hysterectomy in stage IB1-IIA cervical cancer. A prospective randomized study. Eur J Surg Oncol (2012) 0.85
Preoperative MRI criteria for trials on less radical surgery in Stage IB1 cervical cancer. Gynecol Oncol (2014) 0.85
Long-term results of salvage radiotherapy for the treatment of recurrent cervical carcinoma after prior surgery. Radiother Oncol (2008) 0.85
Low-dose, prophylactic, extended-field, intensity-modulated radiotherapy plus concurrent weekly cisplatin for patients with stage IB2-IIIB cervical cancer, positive pelvic lymph nodes, and negative para-aortic lymph nodes. Int J Gynecol Cancer (2014) 0.84
Simple vaginal trachelectomy in early-stage low-risk cervical cancer: a pilot study of 16 cases and review of the literature. Int J Gynecol Cancer (2013) 0.84
Toxicity and cost-effectiveness analysis of intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy for postoperative treatment of gynecologic cancers. Gynecol Oncol (2015) 0.84
First-line chemotherapy with paclitaxel and platinum for advanced and recurrent cancer of the cervix--a phase II study. Gynecol Oncol (1999) 0.84
A retrospective review of patients with stage IB2 cervical cancer treated with radical radiation versus radical surgery as a primary modality. Int J Gynecol Cancer (2013) 0.84
Stage Ia1 cervical squamous cell carcinoma: conservative management after laser conization with positive margins. Gynecol Oncol (2003) 0.84
Neoadjuvant chemotherapy in cervical cancer: a new trend. Curr Opin Obstet Gynecol (2005) 0.83
Microinvasive squamous carcinoma of the cervix: treatment modalities. Acta Obstet Gynecol Scand (2003) 0.83
Potential advantages of intensity-modulated radiation therapy in gynecologic malignancies. Semin Radiat Oncol (2006) 0.83
Cervical conization and sentinel lymph node mapping in the treatment of stage I cervical cancer: is less enough? Int J Gynecol Cancer (2014) 0.82
Role of 18F-FDG PET/CT in detecting pelvic lymph-node metastases in patients with early-stage uterine cervical cancer: comparison with MRI findings. Nucl Med Commun (2014) 0.82
Usefulness of F-18 FDG PET/CT in Assessment of Recurrence of Cervical Cancer After Treatment. Nucl Med Mol Imaging (2011) 0.82
Implementation of laparoscopic approach for type B radical hysterectomy: a comparison with open surgical operations. Eur J Surg Oncol (2014) 0.82
Can laparoscopic radical hysterectomy be a standard surgical modality in stage IA2-IIA cervical cancer? Gynecol Oncol (2012) 0.81
Identifying a low-risk group for parametrial involvement in microscopic Stage IB1 cervical cancer using criteria from ongoing studies and a new MRI criterion. BMC Cancer (2015) 0.80
Class III nerve-sparing radical hysterectomy versus standard class III radical hysterectomy: an observational study. Ann Surg Oncol (2011) 0.80
Management of recurrent cervical cancer. Best Pract Res Clin Obstet Gynaecol (2005) 0.80
A phase II trial of less than 7 weeks of concomitant cisplatin-paclitaxel chemoradiation in locally advanced cervical cancer. Int J Gynecol Cancer (2010) 0.79
Prevalence and determinants of high-risk human papillomavirus infection in women with high socioeconomic status in Seoul, Republic of Korea. Asian Pac J Cancer Prev (2012) 0.79
The value of loop electrosurgical conization in the treatment of stage IA1 microinvasive carcinoma of the uterine cervix. Int J Gynecol Cancer (2002) 0.79
Role of magnetic resonance imaging and positron emission tomography/computed tomography in preoperative lymph node detection of uterine cervical cancer. Am J Obstet Gynecol (2010) 0.79
Phase I study of concurrent chemoradiotherapy with weekly cisplatin and paclitaxel chemotherapy for locally advanced cervical carcinoma in Japanese women. Int J Gynecol Cancer (2009) 0.77
Maximum tolerated dose and early response - results of a phase I trial of paclitaxel and cisplatin with radiation therapy in carcinoma of the cervix. Clin Oncol (R Coll Radiol) (2009) 0.76
Practice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement. J Gynecol Oncol (2016) 0.76
Predictors and Patterns of Local, Regional, and Distant Failure in Squamous Cell Carcinoma of the Vulva. Am J Clin Oncol (2017) 0.76
Outcome analysis of salvage radiotherapy for occult cervical cancer found after simple hysterectomy. Jpn J Clin Oncol (2013) 0.75
Preoperative [F]FDG PET/CT predicts recurrence in patients with epithelial ovarian cancer. J Gynecol Oncol (2012) 0.90
Systemic Inflammatory Response Markers and CA-125 Levels in Ovarian Clear Cell Carcinoma: A Two Center Cohort Study. Cancer Res Treat (2015) 0.90
The Korean guideline for cervical cancer screening. J Gynecol Oncol (2015) 0.87
Primary omental yolk sac tumor. Obstet Gynecol Sci (2013) 0.84
Prognostic implications of PD-L1 expression in patients with soft tissue sarcoma. BMC Cancer (2016) 0.83
MicroRNAs 125a and 125b inhibit ovarian cancer cells through post-transcriptional inactivation of EIF4EBP1. Oncotarget (2016) 0.83
Clinicopathological aspects of patients with recurrence of borderline ovarian tumors. Obstet Gynecol Sci (2015) 0.82
Prognostic role of copeptin after stroke: A systematic review and meta-analysis of observational studies. Sci Rep (2015) 0.82
Single-site robotic surgery in gynecologic cancer: a pilot study. J Gynecol Oncol (2015) 0.81
Position statements on genetic test for peritoneal, ovarian, and fallopian tubal cancers: Korean Society of Gynecologic Oncology (KSGO). J Gynecol Oncol (2016) 0.81
Cost-effectiveness of para-aortic lymphadenectomy before chemoradiotherapy in locally advanced cervical cancer. J Gynecol Oncol (2015) 0.81
Prognostic analysis of uterine cervical cancer treated with postoperative radiotherapy: importance of positive or close parametrial resection margin. Radiat Oncol J (2015) 0.81
Can preoperative MRI accurately evaluate nodal and parametrial invasion in early stage cervical cancer? Jpn J Clin Oncol (2007) 0.80
Controversies in the management of endometrial cancer: a survey of the Korean Gynecologic Oncology Group. J Gynecol Oncol (2015) 0.80
L1 cell adhesion molecule expression is associated with pelvic lymph node metastasis and advanced stage in diabetic patients with endometrial cancer: a matched case control study. J Cancer Prev (2014) 0.80
Incidence of epithelial ovarian cancer according to histologic subtypes in Korea, 1999 to 2012. J Gynecol Oncol (2015) 0.79
Differential Diagnosis of Borderline Ovarian Tumors from Stage I Malignant Ovarian Tumors using FDG PET/CT. Nucl Med Mol Imaging (2013) 0.79
Safety of fertility-sparing surgery in primary mucinous carcinoma of the ovary. Cancer Res Treat (2014) 0.78
Asian Society of Gynecologic Oncology International Workshop 2014. J Gynecol Oncol (2015) 0.77
Meta-analysis reveals no significant correlation between breast cancer survival and ErbB3 expression. APMIS (2015) 0.76
Statin use in spontaneous intracerebral hemorrhage: a systematic review and meta-analysis. Int J Stroke (2015) 0.76
Practice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement. J Gynecol Oncol (2016) 0.76
THE VALIDITY OF THE MOOD DISORDER QUESTIONNAIRE FOR SCREENING BIPOLAR DISORDER: A META-ANALYSIS. Depress Anxiety (2015) 0.76
Long-term outcomes of magnetic resonance imaging-invisible endometrial cancer. J Gynecol Oncol (2016) 0.75
Development and Validation of the Korean Version of Hand-Foot Skin Reaction and Quality of Life Questionnaire (HF-QoL-K). J Korean Med Sci (2016) 0.75
An Alternative Triage Strategy Based on Preoperative MRI for Avoiding Trimodality Therapy in Stage IB Cervical Cancer. Cancer Res Treat (2015) 0.75
Computed tomography-based quantitative assessment of lower extremity lymphedema following treatment for gynecologic cancer. J Gynecol Oncol (2016) 0.75
Comparing and evaluating the efficacy of methotrexate and actinomycin D as first-line single chemotherapy agents in low risk gestational trophoblastic disease. J Gynecol Oncol (2016) 0.75
A Rare Case of an Autoamputated Ovary with Mature Cystic Teratoma. J Menopausal Med (2017) 0.75
Prognostic implications of PIK3CA amplification in curatively resected liposarcoma. Oncotarget (2016) 0.75
Pulmonary metastasectomy in uterine malignancy: outcomes and prognostic factors. J Gynecol Oncol (2015) 0.75
Effects of applying nerve blocks to prevent postherpetic neuralgia in patients with acute herpes zoster: a systematic review and meta-analysis. Korean J Pain (2016) 0.75
Elevated plasma fibrinogen levels and prognosis of epithelial ovarian cancer: a cohort study and meta-analysis. J Gynecol Oncol (2017) 0.75
Comparison of survival outcomes after recurrence detected by cancer antigen 125 elevation versus imaging study in epithelial ovarian cancer. J Gynecol Oncol (2016) 0.75
Surgical manual of the Korean Gynecologic Oncology Group: classification of hysterectomy and lymphadenectomy. J Gynecol Oncol (2016) 0.75
Lymphoepithelioma-like carcinoma of the uterine cervix. Obstet Gynecol Sci (2017) 0.75
Non-puerperal Uterine Inversion Presented with Hypovolemic Shock. J Menopausal Med (2016) 0.75
Endometrial polyp surveillance in premenopausal breast cancer patients using tamoxifen. Obstet Gynecol Sci (2017) 0.75
Prognostic value of metabolic parameters determined by preoperative ¹⁸F-FDG PET/CT in patients with uterine carcinosarcoma. J Gynecol Oncol (2017) 0.75
Acute Respiratory Distress Syndrome after the Use of Gadolinium Contrast Media. Yonsei Med J (2015) 0.75
Robotic high para-aortic lymph node dissection with high port placement using same port for pelvic surgery in gynecologic cancer patients. J Gynecol Oncol (2015) 0.75
Development of the short version of the Gynecologic Cancer Lymphedema Questionnaire: GCLQ-7. J Gynecol Oncol (2016) 0.75
ATP-based chemotherapy response assay in primary or recurrent ovarian and peritoneal cancer. Yonsei Med J (2014) 0.75
HPV vaccine, is it really harmful? J Korean Med Sci (2014) 0.75
Efficacy of loop electrosurgical excision procedure with cold coagulation for treating cervical intraepithelial neoplasia: A two center cohort study. Obstet Gynecol Sci (2017) 0.75
Preventive vaccination against cervical cancer: Korean Society of Gynecologic Oncology Guideline. J Gynecol Oncol (2016) 0.75
Hysteroscopy in fertility-sparing management for early endometrial cancer: a double-edged sword. J Gynecol Oncol (2016) 0.75
Surgical manual of the Korean Gynecologic Oncology Group: ovarian, tubal, and peritoneal cancers. J Gynecol Oncol (2016) 0.75
Knowledge of HPV and Surgery among Women Who Underwent Cervical Conization: A Korean Multi-Center Study. Yonsei Med J (2016) 0.75
Prognostic significance of preoperative ¹⁸F-FDG PET/CT in uterine leiomyosarcoma. J Gynecol Oncol (2017) 0.75
Metastatic follicular struma ovarii complicating pregnancy: a case report and review of the literature. Korean J Hepatobiliary Pancreat Surg (2012) 0.75
Treatment Preferences for Routine Lymphadenectomy Versus No Lymphadenectomy in Early-Stage Endometrial Cancer. Ann Surg Oncol (2016) 0.75
The power of the Risk of Ovarian Malignancy Algorithm considering menopausal status: a comparison with CA 125 and HE4. J Gynecol Oncol (2019) 0.75
Does uneven geographic distribution of urologists effect bladder and prostate cancers mortality? National health insurance data in Korea from 2007-2011. Oncotarget (2017) 0.75
A phase II study of neoadjuvant chemotherapy plus durvalumab and tremelimumab in advanced-stage ovarian cancer: a Korean Gynecologic Oncology Group Study (KGOG 3046), TRU-D. J Gynecol Oncol (2019) 0.75
Oncologic outcomes of adjuvant chemotherapy alone after radical surgery for stage IB-IIA cervical cancer patients. J Gynecol Oncol (2018) 0.75
Safety of fertility-sparing surgery for stage I ovarian clear cell carcinoma. J Gynecol Oncol (2017) 0.75
Robotic or laparoscopic sacrohysteropexy versus open sacrohysteropexy for uterus preservation in pelvic organ prolapse. Int Urogynecol J (2015) 0.75
Does uneven geographic distribution of urologists affect bladder and prostate cancers mortality? national health insurance data in korea from 2007 to 2011. Oncotarget (2017) 0.75
Prognostic significance of normal-sized ovary in advanced serous epithelial ovarian cancer. J Gynecol Oncol (2018) 0.75
Inhaled Corticosteroids and Placebo Treatment Effects in Adult Patients With Cough: A Systematic Review and Meta-analysis. Allergy Asthma Immunol Res (2019) 0.75
Exposure of Surgeons to Magnetic Fields during Laparoscopic and Robotic Gynecologic Surgeries. J Minim Invasive Gynecol (2015) 0.75
Erratum: Author Correction. Management of ovarian cancer patients in affected areas during COVID-19 pandemic: Japan and Korea. J Gynecol Oncol (2020) 0.75